Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosisBMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7475.1163 (Published 11 November 2004) Cite this as: BMJ 2004;329:1163
- Anthony D Harries (email@example.com), technical assistant in HIV care and support1,
- Edwin Libamba, head of unit1,
- Erik J Schouten, technical assistant in HIV/AIDS coordination1,
- Andrina Mwansambo, medical officer in HIV care and support4,
- Felix M Salaniponi, director2,
- Rex Mpazanje, director3
- 1 HIV/AIDS Unit, Ministry of Health, PO Box 30377, Lilongwe, Malawi
- 2 National Tuberculosis Control Programme, Ministry of Health, Malawi
- 3 Department of Clinical Services, Ministry of Health, Malawi
- 4 National AIDS Commission, Lilongwe, Malawi
- Correspondence to: A D Harries
Highly active antiretroviral therapy (HAART) must be expanded in sub-Saharan Africa, where the HIV/AIDS epidemic is taking an appalling toll. Malawi, a small, poor African country, is expanding HAART nationally. The “directly observed treatment, short course” (DOTS) strategy has been successfully used for years to provide effective national control of tuberculosis, and the same concepts are being applied for delivering HAART. We describe how the principles of standardised case finding, standardised treatment regimens, regular monitoring and evaluation, and uninterrupted supplies of drugs can be used to deliver HAART. If implemented well, these principles should ensure a controlled delivery system, which would reduce the risks of inconsistent prescribing practices and the development of drug resistance.
Response to Malawi's HIV/AIDS epidemic
In 2003 sub-Saharan Africa had an estimated 3.4 million new cases of HIV infection and up to 2.4 million deaths.1 Malawi has one of the highest HIV/AIDS prevalence rates in sub-Saharan Africa, with 14% of those aged 15-49 years infected.2 In 2003 an estimated 900 000 people had HIV/AIDS and about 86 000 died from AIDS related illnesses. AIDS is killing young adults in their most productive years, retarding development, producing a huge orphan population, and creating the foundations for political instability.
HAART has dramatically improved the survival of patients with HIV/AIDS in developed countries,3 4 where AIDS is now regarded as a potentially treatable and chronic condition rather than a fatal disease. In Malawi 170 000 people are estimated to need HAART.2 A countrywide survey by the Ministry of Health, however, found that just over 4000 people had started on …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial